T619-3217 Screening compound: 2-[5-({2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}methyl)-1,2,4-oxadiazol-3-yl]pyridine

T619-3217 Screening compound: 2-[5-({2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}methyl)-1,2,4-oxadiazol-3-yl]pyridine
T619-3217 Screening compound: 2-[5-({2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}methyl)-1,2,4-oxadiazol-3-yl]pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound T619-3217
2-[5-({2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}methyl)-1,2,4-oxadiazol-3-yl]pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T619-3217

Molecular Formula

C17H20N6O3 (C17 H20 N6 O3)

Compound Name

2-[5-({2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}methyl)-1,2,4-oxadiazol-3-yl]pyridine

IUPAC name

2-[5-({2-[3-(methoxymethyl)-124-oxadiazol-5-yl]piperidin-1-yl}methyl)-124-oxadiazol-3-yl]pyridine

SMILES

COCc1noc(C2N(Cc3nc(-c4ncccc4)no3)CCCC2)n1

InChI

InChI=1S/C17H20N6O3/c1-24-11-14-19-17(26-21-14)13-7-3-5-9-23(13)10-15-20-16(22-25-15)12-6-2-4-8-18-12/h2,4,6,8,13H,3,5,7,9-11H2,1H3/t13-/m0/s1

InChI Key

WLZJQWGVBPPXMO-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD29027865

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

356.38

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.717

Distribution Coefficient, logD

1.717

Water Solubility, LogSw

-1.76

Polar Surface Area

85.313

Acid Dissociation Constant (pKa)

27.43

Base Dissociation Constant (pKb)

3.32

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.10

T619-3217 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T619-3217 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T619-3217?
Check Price and Availability of T619-3217, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T619-3217 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T619-3217
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T619-3217
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T619-3217 available by request